What is SiMPore?
SiMPore Inc. operates at the intersection of advanced material science and biomedical engineering, specializing in the fabrication of silicon-based nanomembranes. As a prominent player in the bioMEMS sector, the company provides critical infrastructure for researchers, including porous membrane chips and specialized electron microscopy grids. By enabling high-resolution data collection and custom fabrication, SiMPore serves as a foundational partner for institutions engaged in complex life sciences and environmental materials research. Their technical expertise allows for the precise manipulation of molecular and cellular interactions, positioning the firm as an essential provider in the global scientific supply chain.
How much funding has SiMPore raised?
SiMPore has raised a total of $62K across 1 funding round:
Debt
$62K
Debt (2021): $62K with participation from PPP
Key Investors in SiMPore
PPP
Public-Private Partnership
What's next for SiMPore?
With the infusion of this latest capital, SiMPore is well-positioned to accelerate its operational scaling and R&D initiatives. The company is expected to leverage these resources to enhance its manufacturing throughput, meeting the growing demand for high-performance membrane solutions in both clinical and industrial settings. Strategic priorities likely include expanding their product portfolio to address emerging challenges in diagnostic testing and material characterization. As the firm transitions through this growth phase, the focus will remain on maintaining its competitive edge in the bioMEMS market while exploring new commercial partnerships to broaden its reach within the global research community.
See full SiMPore company page
